Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL

Prieto, C.; López-Millán, B.; Roca-Ho, H.; Stam, R. W.; Romero-Moya, D.; Rodríguez-Baena, F. J.; Sanjuan-Pla, A.; Ayllón, V.; Ramírez, M.; Bardini, M.; De Lorenzo, P.; Valsecchi, M. G.; Stanulla, M.; Iglesias, M.; Ballerini, P.; Carcaboso, Á. M.; Mora, J.; Locatelli, F.; Bertaina, A.; Padilla, L.; Rodríguez-Manzaneque, Juan Carlos; Bueno, C.; Menéndez, P.

doi:10.1038/s41375-018-0236-4

Download PDF

Correction
Published: 14 September 2018

Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL

C. Prieto¹,
B. López-Millán¹^na1,
H. Roca-Ho¹^na1,
R. W. Stam^2,3,
D. Romero-Moya¹,
F. J. Rodríguez-Baena⁴,
A. Sanjuan-Pla¹,
V. Ayllón⁴,
M. Ramírez⁵,
M. Bardini⁶,
P. De Lorenzo⁷,
M. G. Valsecchi⁷,
M. Stanulla⁸,
M. Iglesias⁹,
P. Ballerini¹⁰,
Á. M. Carcaboso¹¹,
J. Mora¹¹,
F. Locatelli¹²,
A. Bertaina¹²,
L. Padilla¹³,
Juan Carlos Rodríguez-Manzaneque⁴,
C. Bueno^1,14 &
…
P. Menéndez^1,14,15

Leukemia volume 32, page 2306 (2018)Cite this article

564 Accesses
3 Citations
1 Altmetric
Metrics details

The Original Article was published on 25 September 2017

Correction to: Leukemia; https://doi.org/10.1038/leu.2017.294; published online 17 October 2017

The original version of this Article contained an error in the spelling of the author Juan Carlos Rodriguez-Manzaneque, which was incorrectly given as J Carlos Rodríguez-Manzaneque. This has now been corrected in both the PDF and HTML versions of the Article.

Author information

These authors contributed equally: B López-Millán, H Roca-Ho.

Authors and Affiliations

Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine,, University of Barcelona, Barcelona, Spain
C. Prieto, B. López-Millán, H. Roca-Ho, D. Romero-Moya, A. Sanjuan-Pla, C. Bueno & P. Menéndez
Erasmus University Medical Center, Rotterdam, The Netherlands
R. W. Stam
Princess Maxima Center for Paediatric Oncology, Utrecht, The Netherlands
R. W. Stam
GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain
F. J. Rodríguez-Baena, V. Ayllón & Juan Carlos Rodríguez-Manzaneque
Oncohematología, Hospital Universitario Niño Jesús, Madrid, Spain
M. Ramírez
Centro Ricerca Tettamanti, University of Milano-Bicocca, Ospedale San Gerardo Monza, Italy
M. Bardini
Interfant Trial Data Center, University of Milano-Bicocca, Monza, Italy
P. De Lorenzo & M. G. Valsecchi
Department of Pediatric Hemato-Oncology, Hannover Medical School, Hannover, Germany
M. Stanulla
Pathology Service, Hospital del Mar, Barcelona, Spain
M. Iglesias
Pediatric Hematology, A. Trousseau Hospital, Paris, France
P. Ballerini
Developmental Tumor Biology Laboratory, Hospital Sant Joan de Deu, Barcelona, Spain
Á. M. Carcaboso & J. Mora
Department of Pediatric Hematology and Oncology, Ospedale Bambino Gesù, Rome, University of Pavia, Pavia, Italy
F. Locatelli & A. Bertaina
Biomed Division, LEITAT Technological Centre, Barcelona, Spain
L. Padilla
Centro de Investigacion Biomedica en Red-Oncología (CIBERONC), Barcelona, Spain
C. Bueno & P. Menéndez
Instituciò Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
P. Menéndez

Authors

C. Prieto
View author publications
You can also search for this author in PubMed Google Scholar
B. López-Millán
View author publications
You can also search for this author in PubMed Google Scholar
H. Roca-Ho
View author publications
You can also search for this author in PubMed Google Scholar
R. W. Stam
View author publications
You can also search for this author in PubMed Google Scholar
D. Romero-Moya
View author publications
You can also search for this author in PubMed Google Scholar
F. J. Rodríguez-Baena
View author publications
You can also search for this author in PubMed Google Scholar
A. Sanjuan-Pla
View author publications
You can also search for this author in PubMed Google Scholar
V. Ayllón
View author publications
You can also search for this author in PubMed Google Scholar
M. Ramírez
View author publications
You can also search for this author in PubMed Google Scholar
M. Bardini
View author publications
You can also search for this author in PubMed Google Scholar
P. De Lorenzo
View author publications
You can also search for this author in PubMed Google Scholar
M. G. Valsecchi
View author publications
You can also search for this author in PubMed Google Scholar
M. Stanulla
View author publications
You can also search for this author in PubMed Google Scholar
M. Iglesias
View author publications
You can also search for this author in PubMed Google Scholar
P. Ballerini
View author publications
You can also search for this author in PubMed Google Scholar
Á. M. Carcaboso
View author publications
You can also search for this author in PubMed Google Scholar
J. Mora
View author publications
You can also search for this author in PubMed Google Scholar
F. Locatelli
View author publications
You can also search for this author in PubMed Google Scholar
A. Bertaina
View author publications
You can also search for this author in PubMed Google Scholar
L. Padilla
View author publications
You can also search for this author in PubMed Google Scholar
Juan Carlos Rodríguez-Manzaneque
View author publications
You can also search for this author in PubMed Google Scholar
C. Bueno
View author publications
You can also search for this author in PubMed Google Scholar
P. Menéndez
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to C. Bueno or P. Menéndez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prieto, C., López-Millán, B., Roca-Ho, H. et al. Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL. Leukemia 32, 2306 (2018). https://doi.org/10.1038/s41375-018-0236-4

Download citation

Published: 14 September 2018
Issue Date: October 2018
DOI: https://doi.org/10.1038/s41375-018-0236-4

This article is cited by

Clinical-biological characteristics and treatment outcomes of pediatric pro-B ALL patients enrolled in BCH-2003 and CCLG-2008 protocol: a study of 121 Chinese children
- Chao Gao
- Shu-Guang Liu
- Rui-Dong Zhang
Cancer Cell International (2019)
Redirecting T cells to treat solid pediatric cancers
- Kerstin K. Rauwolf
- Claudia Rossig
Cancer and Metastasis Reviews (2019)

Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL

Author information

Authors and Affiliations

Corresponding authors

Rights and permissions

About this article

Cite this article

This article is cited by

Clinical-biological characteristics and treatment outcomes of pediatric pro-B ALL patients enrolled in BCH-2003 and CCLG-2008 protocol: a study of 121 Chinese children

Redirecting T cells to treat solid pediatric cancers

Search

Quick links

Author information

Authors and Affiliations

Corresponding authors

Rights and permissions

About this article

Cite this article

Share this article

This article is cited by

Clinical-biological characteristics and treatment outcomes of pediatric pro-B ALL patients enrolled in BCH-2003 and CCLG-2008 protocol: a study of 121 Chinese children

Redirecting T cells to treat solid pediatric cancers

Search

Quick links